Australia - englanti - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - ropivacaine hydrochloride, quantity: 2 mg/ml - injection, intravenous infusion - excipient ingredients: sodium chloride; sodium hydroxide; hydrochloric acid; water for injections - analgesia (adults and children over 12 years of age) ? continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain (excluding intermittent top up injections) ? field block (minor nerve block and infiltration) ? continuous peripheral nerve block infusion or intermittent injections for post ? operative pain management ? continuous wound infusion for postoperative pain management (adults only) analgesia (children aged 0 - 12 years) ? continuous epidural infusion in infants (> 30 days and over 2500 g weight) and children up to and including 12 years,for peri- and postoperative pain management. there are no safety or efficacy data to support the use of ropivacaine-aft for analgesia for longer than 72 hours. (data for peripheral nerve block administered as a continuous peripheral infusion or intermittent injections and for continuous wound infusion support the use for up to 48 hours only).

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

pinewood laboratories ltd - flucloxacillin sodium monohydrate - powder for solution for injection/infusion - 1 gram(s) - beta-lactamase resistant penicillins; flucloxacillin

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

pinewood laboratories ltd - flucloxacillin sodium monohydrate - powder for solution for injection/infusion - 250 milligram(s) - beta-lactamase resistant penicillins; flucloxacillin

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

pinewood laboratories ltd - flucloxacillin sodium monohydrate - powder for solution for injection/infusion - 500 milligram(s) - beta-lactamase resistant penicillins; flucloxacillin

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - ropivacaine hydrochloride 2 mg/ml - solution for infusion - 2 mg/ml - active: ropivacaine hydrochloride 2 mg/ml excipient: hydrochloric acid nitrogen sodium chloride sodium hydroxide water for injection - surgical analgesia - epidural block for surgery, including caesarean section - intrathecal block - major nerve block - field block (minor nerve block and infiltration)

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

teva b.v. - flucloxacillin - powder for solution for injection/infusion - beta-lactamase resistant penicillins; flucloxacillin

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

teva b.v. - flucloxacillin - powder for solution for injection/infusion - beta-lactamase resistant penicillins; flucloxacillin

Nigeria - englanti - NAFDAC (National Agency for Food and Drugs Administration and Control)

paracetamol 150mg,lignocaine 1%

Australia - englanti - Department of Health (Therapeutic Goods Administration)

orphan australia pty ltd - morphine sulfate -

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

flynn pharma ltd - nizatidine - capsules hard - 300 milligram